Walgreens Boots Alliance (WBA) Earns Media Impact Score of 0.14

News coverage about Walgreens Boots Alliance (NASDAQ:WBA) has trended somewhat positive this week, according to Accern Sentiment Analysis. Accern ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Walgreens Boots Alliance earned a news impact score of 0.14 on Accern’s scale. Accern also gave press coverage about the pharmacy operator an impact score of 47.2074924396811 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

These are some of the news stories that may have effected Accern Sentiment’s scoring:

How to Become a New Pot Stock Millionaire

NASDAQ WBA traded down $0.20 during trading on Tuesday, hitting $66.02. 4,248,639 shares of the stock traded hands, compared to its average volume of 5,893,140. The stock has a market capitalization of $63,288.10, a PE ratio of 12.93, a P/E/G ratio of 1.03 and a beta of 1.16. Walgreens Boots Alliance has a 12-month low of $61.74 and a 12-month high of $87.79. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.90 and a quick ratio of 0.45.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Wednesday, March 28th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.18. The business had revenue of $33.02 billion during the quarter, compared to analyst estimates of $32.20 billion. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The company’s revenue for the quarter was up 12.1% on a year-over-year basis. During the same period last year, the company earned $1.36 EPS. analysts anticipate that Walgreens Boots Alliance will post 5.95 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 12th. Stockholders of record on Friday, May 18th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.42%. The ex-dividend date is Thursday, May 17th. Walgreens Boots Alliance’s payout ratio is 31.37%.

A number of research firms have weighed in on WBA. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $82.00 target price on the stock in a report on Saturday, January 13th. Pivotal Research set a $70.00 target price on Walgreens Boots Alliance and gave the company a “hold” rating in a report on Thursday, March 29th. BidaskClub downgraded Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Thursday, March 22nd. Robert W. Baird restated a “buy” rating and issued a $82.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, January 4th. Finally, Jefferies Group set a $85.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Tuesday, April 3rd. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. Walgreens Boots Alliance presently has a consensus rating of “Buy” and a consensus target price of $83.20.

ILLEGAL ACTIVITY NOTICE: This piece was posted by Week Herald and is owned by of Week Herald. If you are reading this piece on another site, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this piece can be read at https://weekherald.com/2018/04/17/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-walgreens-boots-alliance-wba-stock-price.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Insider Buying and Selling by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply